R. Kuse

4.1k total citations
78 papers, 2.4k citations indexed

About

R. Kuse is a scholar working on Hematology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, R. Kuse has authored 78 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 27 papers in Pathology and Forensic Medicine and 23 papers in Oncology. Recurrent topics in R. Kuse's work include Lymphoma Diagnosis and Treatment (25 papers), Acute Myeloid Leukemia Research (24 papers) and Chronic Lymphocytic Leukemia Research (16 papers). R. Kuse is often cited by papers focused on Lymphoma Diagnosis and Treatment (25 papers), Acute Myeloid Leukemia Research (24 papers) and Chronic Lymphocytic Leukemia Research (16 papers). R. Kuse collaborates with scholars based in Germany, Italy and Netherlands. R. Kuse's co-authors include Dieter K. Hossfeld, Stefan Suciu, Norbert Schmitz, Ruth Sonnen, Wolfgang Hiddemann, K. Hausmann, Nicolaus Kröger, Dieter K. Hossfeld, Rainer Schwerdtfeger and D. Urbanitz and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Internal Medicine.

In The Last Decade

R. Kuse

69 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Kuse Germany 26 1.4k 763 734 703 518 78 2.4k
Anna Porwit‐MacDonald Sweden 30 1.1k 0.8× 938 1.2× 604 0.8× 631 0.9× 610 1.2× 50 2.7k
Françoise Rigal‐Huguet France 25 1.3k 0.9× 1.0k 1.3× 869 1.2× 837 1.2× 692 1.3× 66 2.7k
Ester Orlandi Italy 26 1.2k 0.9× 771 1.0× 546 0.7× 1.3k 1.8× 360 0.7× 95 2.4k
MJ Keating United States 30 1.2k 0.9× 983 1.3× 853 1.2× 1.7k 2.4× 648 1.3× 54 3.1k
Michael J. Barnett Canada 30 1.8k 1.3× 712 0.9× 698 1.0× 1.0k 1.5× 474 0.9× 115 2.9k
Z Arlin United States 27 1.7k 1.2× 413 0.5× 766 1.0× 820 1.2× 725 1.4× 71 2.8k
Lourdes Escoda Spain 20 977 0.7× 551 0.7× 567 0.8× 519 0.7× 665 1.3× 57 1.7k
Shin Fujisawa Japan 27 1.1k 0.8× 410 0.5× 572 0.8× 561 0.8× 380 0.7× 182 2.2k
Benet Nomdedeu Spain 22 881 0.6× 592 0.8× 349 0.5× 829 1.2× 361 0.7× 88 1.8k
S N Wolff United States 16 1.1k 0.7× 352 0.5× 863 1.2× 292 0.4× 423 0.8× 22 2.1k

Countries citing papers authored by R. Kuse

Since Specialization
Citations

This map shows the geographic impact of R. Kuse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Kuse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Kuse more than expected).

Fields of papers citing papers by R. Kuse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Kuse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Kuse. The network helps show where R. Kuse may publish in the future.

Co-authorship network of co-authors of R. Kuse

This figure shows the co-authorship network connecting the top 25 collaborators of R. Kuse. A scholar is included among the top collaborators of R. Kuse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Kuse. R. Kuse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuse, R., et al.. (2008). Überlebensraten bei Morbus Hodgkin in Beziehung zu den histologischen Subtypen. DMW - Deutsche Medizinische Wochenschrift. 106(18). 571–574.
2.
4.
Kröger, Nicolaus, Rainer Schwerdtfeger, Michael Kiehl, et al.. (2002). Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma. Blood. 100(3). 755–760. 188 indexed citations
5.
Sonnen, Ruth, Wolf‐Peter Schmidt, R. Kuse, & Norbert Schmitz. (2002). Treatment results of aggressive B non‐Hodgkin's lymphoma in advanced age considering comorbidity. British Journal of Haematology. 119(3). 634–639. 9 indexed citations
6.
Kröger, Nicolaus, W. Zeller, Helmut Renges, et al.. (1999). Efficacy of Further Attempts to Mobilize CD34+ Peripheral Stem Cells with Alternative Procedures after Primary Failure. Acta Haematologica. 102(3). 144–147. 5 indexed citations
7.
Vohwinkel, Gabi, et al.. (1999). Origin of stroma cells in long-term bone marrow cultures from patients with acute myeloid leukemia. Annals of Hematology. 78(7). 305–314. 21 indexed citations
8.
Rosenwald, Andreas, German Ott, Tiemo Katzenberger, et al.. (1999). Jumping Translocation of 1q as the Sole Aberration in a Case of Follicular Lymphoma. Cancer Genetics and Cytogenetics. 108(1). 53–56. 8 indexed citations
9.
Dreger, Peter, Nils von Neuhoff, R. Kuse, et al.. (1998). Early stem cell transplantation for chronic lymphocytic leukaemia: a chance for cure?. British Journal of Cancer. 77(12). 2291–2297. 43 indexed citations
11.
Dreger, Peter, Nils von Neuhoff, R. Kuse, et al.. (1997). Sequential high-dose therapy and autologous stem cell transplantation for treatment of mantle cell lymphoma. Annals of Oncology. 8(4). 401–403. 19 indexed citations
12.
Schlegelberger, Brigitte, T. Zwingers, Karin Hohenadel, et al.. (1996). Significance of cytogenetic findings for the clinical outcome in patients with T-cell lymphoma of angioimmunoblastic lymphadenopathy type.. Journal of Clinical Oncology. 14(2). 593–599. 41 indexed citations
13.
Pfreundschuh, Michael, U. Rueffer, B. Lathan, et al.. (1994). Dexa-BEAM in patients with Hodgkin's disease refractory to multidrug chemotherapy regimens: a trial of the German Hodgkin's Disease Study Group.. Journal of Clinical Oncology. 12(3). 580–586. 95 indexed citations
14.
Siegert, W., Alexander G Agthe, Henrik Griesser, et al.. (1992). Treatment of Angioimmunoblastic Lymphadenopathy (AILD)-Type T-Cell Lymphoma Using Prednisone with or without the COPBLAM/IMVP-16 Regimen. Annals of Internal Medicine. 117(5). 364–370. 89 indexed citations
15.
Wen, Hui‐Ju, R. Kuse, & Dieter K. Hossfeld. (1990). Acute nonlymphocytic leukemia (ANLL) with isochromosome i(17q) as the sole chromosomal anomaly: a distinct entity?. European Journal Of Haematology. 44(5). 312–314. 13 indexed citations
16.
Kuse, R., et al.. (1985). Blood lymphocyte volumes and diameters in patients with chronic lymphocytic leukemia and normal controls. Annals of Hematology. 50(4). 243–248. 37 indexed citations
17.
Hausmann, K., et al.. (1985). Risk of transformation survival rates and prognostic factors in 338 patients with myelodysplastic syndromes. Annals of Hematology. 51(3). 162. 3 indexed citations
18.
Kuse, R., et al.. (1979). [Staging of Hodgkin's disease by postprimary laparotomy: therapeutic consequences].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 50(8). 484–9.
19.
Kuse, R. & K. Hausmann. (1975). Fehlermöglichkeiten der leukozytenzählung durch Verschleppung (carryover) im coulter counter S. Annals of Hematology. 30(2). 107–120. 3 indexed citations
20.
Heinrich, H. C., E. E. Gabbe, Dong Hee Whang, et al.. (1971). Diagnostischer59Fe2+-Resorptions-Test und diffus verteiltes Reserveeisen der Knochenmarksmakrophagen bei Magenmucosaatrophie und nach Magen-2/3-Resektion bzw. totaler Gastrektomie. Journal of Molecular Medicine. 49(14). 825–835. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026